Loading the records…
Loading the records…
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Onyia Jude, holds the title of Chief Scientific Officer at NEUROCRINE BIOSCIENCES INC.
On 2026-06-05, the insider transacted 2,441 shares.This transaction is a non-open-market event (such as a stock grant or option exercise) with a reported price per share of $0.00.
Onyia Jude (Chief Scientific Officer) gifted $0 of $NBIX
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.